SCHEMBL484811

SCHEMBL484811

O=C(NC1CCc2ccc(C(=O)N3CCC4(CCN(Cc5ccc6nccnc6c5)CC4)C3)cc21)c1cc(Cl)ccc1F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACKR3 P25106 1/20 0.38
ENPP2 Q13822 6/20 0.37
ATXN2 Q99700 6/20 0.37
CYP2D6 P10635 3/20 0.37
CYP3A4 P08684 2/20 0.37
CYP2C9 P11712 2/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2C19 P33261 1/20 0.37
CHRM2 P08172 1/20 0.37
CHRM3 P20309 1/20 0.37
DRD2 P14416 2/20 0.36
KCNH2 Q12809 2/20 0.36
HTR1A P08908 1/20 0.36
HTR2A P28223 1/20 0.36
USP2 O75604 1/20 0.36
ALDH1A1 P00352 1/20 0.36
HPGD P15428 1/20 0.36
SLC6A4 P31645 1/20 0.36
MCHR2 Q969V1 1/20 0.36
MCHR1 Q99705 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2822137 0.96 CYP3A4 (0.41) ACKR3CYP2D6CYP3A4CYP2C9CYP1A2
SCHEMBL2816320 0.93 MCHR1 (0.45) ACKR3ENPP2ATXN2CYP2D6CYP3A4
SCHEMBL2819125 0.92 ACKR3 (0.40) ACKR3CYP2D6CYP3A4CYP2C9CYP1A2
SCHEMBL484785 0.89 ACKR3 (0.40) ACKR3CYP2D6CYP3A4CYP2C9CYP1A2
SCHEMBL485047 0.89 MCHR1 (0.46) ACKR3CYP2D6CYP3A4CYP2C9CYP1A2
SCHEMBL485147 0.88 HSD11B1 (0.36) ACKR3CHRM2CHRM3DRD2KCNH2
SCHEMBL484843 0.88 CYP2D6 (0.41) ACKR3ENPP2ATXN2CYP2D6CYP3A4
SCHEMBL485317 0.88 ACKR3 (0.39) ACKR3CYP2D6CYP3A4CYP2C9CYP1A2
SCHEMBL484372 0.88 CYP3A4 (0.49) CYP2D6CYP3A4CYP2C9CYP1A2CYP2C19
SCHEMBL484783 0.87 CHRM2 (0.45) ACKR3CYP2D6CYP3A4CYP2C9CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US claimed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US claimed
EP-2411381-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2012-02-01 EP claimed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US claimed
WO-2010108651-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2010-09-30 WO claimed
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US disclosed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US disclosed
EP-2411381-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2012-02-01 EP disclosed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US disclosed
WO-2010108651-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2010-09-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130231327-A1 Substituted Spiro-Amide Compounds BDKRB1, BDKRB2, REN ACKR3 90/4885ENPP2 914/4885ATXN2 3604/4885
US-20100249095-A1 Substituted Spiro-amide Compounds BDKRB1, BDKRB2, REN ACKR3 90/4885ENPP2 914/4885ATXN2 3604/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.